Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States

E. Eugene Marsh, H. P. Adams, J. Biller, P. Wasek, K. Banwart, V. Mitchell, R. Woolson

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Inan attempt to determine the opinions and practices of neurologists regarding the use of antithrombotic drugs in the treatment of acute ischemic stroke, we conducted a survey of 349 randomly selected neurologists from throughout the United States. Responses were received from 247 (71%), and 219 identified themselves as primary or consulting physicians for patients with acute ischemic stroke. During the previous 12 months, these 219 physicians estimated that they had seen a total of 14,636 patients within 24 hours of acute ischemic stroke, and 22% of these patients were treated with heparin. The most frequently reported indications were prevention of recurrent cerebral embolism (82% of physicians) and progressing stroke (70%). Despite the frequent use of heparin, only 6.4% of neurologists felt that it has been shown to be effective, and 16.4% felt that it has been shown to be of no value. The primary concern about the use of heparin was lack of proven efficacy in 48% and safety concerns in 41%. Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke.

Original languageEnglish (US)
Pages (from-to)1631-1634
Number of pages4
JournalNeurology
Volume39
Issue number12
StatePublished - Jan 1 1989

Fingerprint

Stroke
Heparin
Pharmaceutical Preparations
Physicians
Therapeutics
Intracranial Embolism
Neurologists
Surveys and Questionnaires
Safety

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Marsh, E. E., Adams, H. P., Biller, J., Wasek, P., Banwart, K., Mitchell, V., & Woolson, R. (1989). Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States. Neurology, 39(12), 1631-1634.
Marsh, E. Eugene ; Adams, H. P. ; Biller, J. ; Wasek, P. ; Banwart, K. ; Mitchell, V. ; Woolson, R. / Use of antithrombotic drugs in the treatment of acute ischemic stroke : A survey of neurologists in practice in the United States. In: Neurology. 1989 ; Vol. 39, No. 12. pp. 1631-1634.
@article{7ccd67069ab549759edff9ba5e9e39ba,
title = "Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States",
abstract = "Inan attempt to determine the opinions and practices of neurologists regarding the use of antithrombotic drugs in the treatment of acute ischemic stroke, we conducted a survey of 349 randomly selected neurologists from throughout the United States. Responses were received from 247 (71{\%}), and 219 identified themselves as primary or consulting physicians for patients with acute ischemic stroke. During the previous 12 months, these 219 physicians estimated that they had seen a total of 14,636 patients within 24 hours of acute ischemic stroke, and 22{\%} of these patients were treated with heparin. The most frequently reported indications were prevention of recurrent cerebral embolism (82{\%} of physicians) and progressing stroke (70{\%}). Despite the frequent use of heparin, only 6.4{\%} of neurologists felt that it has been shown to be effective, and 16.4{\%} felt that it has been shown to be of no value. The primary concern about the use of heparin was lack of proven efficacy in 48{\%} and safety concerns in 41{\%}. Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke.",
author = "Marsh, {E. Eugene} and Adams, {H. P.} and J. Biller and P. Wasek and K. Banwart and V. Mitchell and R. Woolson",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "39",
pages = "1631--1634",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

Marsh, EE, Adams, HP, Biller, J, Wasek, P, Banwart, K, Mitchell, V & Woolson, R 1989, 'Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States', Neurology, vol. 39, no. 12, pp. 1631-1634.

Use of antithrombotic drugs in the treatment of acute ischemic stroke : A survey of neurologists in practice in the United States. / Marsh, E. Eugene; Adams, H. P.; Biller, J.; Wasek, P.; Banwart, K.; Mitchell, V.; Woolson, R.

In: Neurology, Vol. 39, No. 12, 01.01.1989, p. 1631-1634.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of antithrombotic drugs in the treatment of acute ischemic stroke

T2 - A survey of neurologists in practice in the United States

AU - Marsh, E. Eugene

AU - Adams, H. P.

AU - Biller, J.

AU - Wasek, P.

AU - Banwart, K.

AU - Mitchell, V.

AU - Woolson, R.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Inan attempt to determine the opinions and practices of neurologists regarding the use of antithrombotic drugs in the treatment of acute ischemic stroke, we conducted a survey of 349 randomly selected neurologists from throughout the United States. Responses were received from 247 (71%), and 219 identified themselves as primary or consulting physicians for patients with acute ischemic stroke. During the previous 12 months, these 219 physicians estimated that they had seen a total of 14,636 patients within 24 hours of acute ischemic stroke, and 22% of these patients were treated with heparin. The most frequently reported indications were prevention of recurrent cerebral embolism (82% of physicians) and progressing stroke (70%). Despite the frequent use of heparin, only 6.4% of neurologists felt that it has been shown to be effective, and 16.4% felt that it has been shown to be of no value. The primary concern about the use of heparin was lack of proven efficacy in 48% and safety concerns in 41%. Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke.

AB - Inan attempt to determine the opinions and practices of neurologists regarding the use of antithrombotic drugs in the treatment of acute ischemic stroke, we conducted a survey of 349 randomly selected neurologists from throughout the United States. Responses were received from 247 (71%), and 219 identified themselves as primary or consulting physicians for patients with acute ischemic stroke. During the previous 12 months, these 219 physicians estimated that they had seen a total of 14,636 patients within 24 hours of acute ischemic stroke, and 22% of these patients were treated with heparin. The most frequently reported indications were prevention of recurrent cerebral embolism (82% of physicians) and progressing stroke (70%). Despite the frequent use of heparin, only 6.4% of neurologists felt that it has been shown to be effective, and 16.4% felt that it has been shown to be of no value. The primary concern about the use of heparin was lack of proven efficacy in 48% and safety concerns in 41%. Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke.

UR - http://www.scopus.com/inward/record.url?scp=0024806032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024806032&partnerID=8YFLogxK

M3 - Article

C2 - 2586780

AN - SCOPUS:0024806032

VL - 39

SP - 1631

EP - 1634

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -